SEARCH

SEARCH BY CITATION

References

  • Arnold, D.M., Dentali, F., Crowther, M.A., Meyer, R.M., Cook, R.J., Sigouin, C., Fraser, G.A., Lim, W. & Kelton, J.G. (2007) Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura. Annals of Internal Medicine, 146, 2533.
  • Boileau, J., Mouillot, G., Gérard, L., Carmagnat, M., Rabian, C., Oksenhendler, E., pasquali, JL., Korganow, AS. & DEFI study group (2011) Autoimmunity in common variable immunodeficiency: correlation with lymphocyte phenotype in the French DEFI study. Journal of Autoimmunity, 36, 2532.
  • Bussel, J.B., Graziano, J.N., Kimberly, R.P., Pahwa, S. & Aledort, L.M. (1991) Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect. Blood, 77, 18841893.
  • Bussone, G., Ribeiro, E., Dechartres, A., Viallard, J.F., Bonnotte, B., Fain, O., Godeau, B. & Michel, M. (2009) Efficacy and safety of rituximab in adults’ warm antibody autoimmune haemolytic anemia: retrospective analysis of 27 cases. American Journal of Hematology, 84, 153157.
  • Cambridge, G., Leandro, M.J., Edwards, J.C., Ehrenstein, M.R., Salden, M., Bodman-Smith, M. & Webster, A.D. (2003) Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis & Rheumatism, 48, 21462154.
  • Carbone, J., Escudero, A., Mayayo, M., Ballesteros, M., Perez-Corral, A., Sanchez-Ramon, S., Sarmiento, E., Micheloud, D. & Fernandez-Cruz, E. (2005) Partial response to anti-CD20 monoclonal antibody treatment of severe immune thrombocytopenic purpura in a patient with common variable immunodeficiency. Annals New York Academy of Sciences, 1051, 666671.
  • Chapel, H., Lucas, M., Lee, M., Bjorkander, J., Webster, D., Grimbacher, B., Fieschi, C., Thon, V., Abedi, M.R. & Hammarstrom, L. (2008) Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood, 112, 277286.
  • Conley, M.E., Notarangelo, L.D. & Etzioni, A. (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clinical Immunology, 93, 190197.
  • Cooper, N., Stasi, R., Cunningham-Rundles, S., Feuerstein, M.A., Leonard, J.P., Amadori, S. & Bussel, J.B. (2004) The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura. British Journal of Haematology, 125, 232239.
  • Cunningham-Rundles, C. (2002) Hematologic complications of primary immune deficiencies. Blood Reviews, 16, 6164.
  • Cunningham-Rundles, C. & Bodian, C. (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clinical Immunology, 92, 3448.
  • Edwards, J.C. & Cambridge, G. (2006) B-cell targeting in rheumatoid arthritis and other autoimmune diseases. Nature Reviews Immunology, 6, 394403.
  • El-Shanawany, T.M., Williams, P.E. & Jolles, S. (2007) Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab. Journal of Clinical Pathology, 60, 715716.
  • Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology, 141, 149169.
  • Godeau, B., Porcher, R., Fain, O., Lefrere, F., Fenaux, P., Cheze, S., Vekhoff, A., Chauveheid, M.P., Stirnemann, J., Galicier, L., Bourgeois, E., Haiat, S., Varet, B., Leporrier, M., Papo, T., Khellaf, M., Michel, M. & Bierling, P. (2008) Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study. Blood, 112, 9991004.
  • Kim, J.J., Thrasher, A.J., Jones, A.M., Davies, E.G. & Cale, C.M. (2007) Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency. British Journal of Haematology, 138, 9496.
  • Lund, F. & Randall, T.E. (2010) effector and regulatory B cells: modulators of CD4+ T cell immunity. Nature Reviews Immunology, 4, 236247.
  • Michel, M., Chanet, V., Galicier, L., Ruivard, M., Levy, Y., Hermine, O., Oksenhendler, E., Schaeffer, A., Bierling, P. & Godeau, B. (2004) Autoimmune thrombocytopenic purpura and common variable immunodeficiency: analysis of 21 cases and review of the literature. Medicine (Baltimore), 83, 254263.
  • Michel, M., Chanet, V., Dechartres, A., Morin, A.S., Piette, J.C., Cirasino, L., Emilia, G., Zaja, F., Ruggeri, M., Andres, E., Bierling, P., Godeau, B. & Rodeghiero, F. (2009) The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood, 114, 31673172.
  • Oksenhendler, E., Gerard, L., Fieschi, C., Malphettes, M., Mouillot, G., Jaussaud, R., Viallard, J.F., Gardembas, M., Galicier, L., Schleinitz, N., Suarez, F., Soulas-Sprauel, P., Hachulla, E., Jaccard, A., Gardeur, A., Theodorou, I., Rabian, C. & Debre, P. (2008) Infections in 252 patients with common variable immunodeficiency. Clinical Infectious Diseases, 46, 15471554.
  • Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kuhne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 23862393.
  • Seve, P., Bourdillon, L., Sarrot-Reynauld, F., Ruivard, M., Jaussaud, R., Bouhour, D., Bonotte, B., Gardembas, M., Poindron, V., Thiercelin, M.F., Broussolle, C. & Oksenhendler, E. (2008) Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of 18 patients. Medicine (Baltimore), 87, 177184.
  • Sicherer, S.H. & Winkelstein, J.A. (1998) Primary immunodeficiency diseases in adults. Journal of the American Medical Association, 279, 5861.
  • Smith, K.G., Jones, R.B., Burns, S.M. & Jayne, D.R. (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis & Rheumatism, 54, 29702982.
  • Sneller, M.C., Strober, W., Eisenstein, E., Jaffe, J.S. & Cunningham-Rundles, C. (1993) NIH conference. New insights into common variable immunodeficiency. Annals of Internal Medicine, 118, 720730.
  • Stasi, R., Del Poeta, G., Stipa, E., Evangelista, M.L., Trawinska, M.M., Cooper, N. & Amadori, S. (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood, 110, 29242930.
  • Stray-Pedersen, A., Abrahamsen, T.G. & Froland, S.S. (2000) Primary immunodeficiency diseases in Norway. Journal of Clinical Immunology, 20, 477485.
  • Strober, W. & Chua, K. (2000) Common variable immunodeficiency. Clinical Reviews in Allergy & Immunology, 19, 157181.
  • Taylor, R.P. & Lindorfer, M.A. (2008) Immunotherapeutic mechanisms of anti-CD20 monoclonal antibodies. Current Opinion in Immunology, 20, 444449.
  • Wakim, M., Shah, A., Arndt, P.A., Garratty, G., Weinberg, K., Hofstra, T. & Church, J. (2004) Successful anti-CD20 monoclonal antibody treatment of severe autoimmune hemolytic anemia due to warm reactive IgM autoantibody in a child with common variable immunodeficiency. American Journal of Hematology, 76, 152155.
  • Wang, J. & Cunningham-Rundles, C. (2005) Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). Journal of Autoimmunity, 25, 5762.
  • Zaja, F., Baccarani, M., Mazza, P., Bocchia, M., Gugliotta, L., Zaccaria, A., Vianelli, N., Defina, M., Tieghi, A., Amadori, S., Campagna, S., Ferrara, F., Angelucci, E., Usala, E., Cantoni, S., Visani, G., Fornaro, A., Rizzi, R., De Stefano, V., Casulli, F., Battista, M.L., Isola, M., Soldano, F., Gamba, E. & Fanin, R. (2010) Dexamethasone plus rituximab yields higher sustained response rates than dexamethasone monotherapy in adults with primary immune thrombocytopenia. Blood, 115, 27552762.